Search results for "Supportive psychotherapy"

showing 9 items of 9 documents

Cognitive-behavioral therapy and psychodynamic psychotherapy: techniques, efficacy, and indications.

2006

In this article, we provide an overview of the techniques and efficacy of the two most commonly used psychotherapeutic treatments of psychiatric disorders in adults: cognitive-behavioral and psychodynamic therapy. Psychotherapeutic techniques, major indications, and empirical evidence will be presented. The focus will be on empirically supported models of treatment.Cognitive-behavioral therapy and psychodynamic psychotherapy are the most frequently applied methods of psychotherapy in clinical practice.To give an up-to-date description of cognitive-behavioral therapy and psychodynamic psychotherapy and to review empirical evidence for efficacy in specific mental disorders.Systematic reviews …

050103 clinical psychologyPsychotherapistmedicine.medical_treatmentTreatment outcomePsychological interventionPerson-centered therapy03 medical and health sciences0302 clinical medicinemedicineHumans0501 psychology and cognitive sciencesPsychodynamic psychotherapyEvidence-Based MedicineCognitive Behavioral TherapyMental Disorders05 social sciencesGeneral Medicine3. Good health030227 psychiatryCognitive behavioral therapyPsychotherapyClinical PsychologyTreatment OutcomeSupportive psychotherapyTherapie cognitiveCognitive therapyPsychologyClinical psychologyAmerican journal of psychotherapy
researchProduct

Deferiprone versus Deferoxamine in Sickle Cell Disease: Results from a 5-year long-term Italian multi-center randomized clinical trial

2014

Blood transfusion and iron chelation currently represent a supportive therapy to manage anemia, vasculopathy and vaso-occlusion crises in Sickle-Cell-Disease. Here we describe the first 5-year long-term randomized clinical trial comparing Deferiprone versus Deferoxamine in patients with Sickle-Cell-Disease. The results of this study show that Deferiprone has the same effectiveness as Deferoxamine in decreasing body iron burden, measured as repeated measurements of serum ferritin concentrations on the same patient over 5-years and analyzed according to the linear mixed-effects model (LMM) (p=0.822). Both chelators are able to decrease, significantly, serum ferritin concentrations, during 5-y…

AdultMalemedicine.medical_specialtyIron OverloadBlood transfusionAdolescentPyridonesAnemiaIronmedicine.medical_treatmentAnemia Sickle CellDeferoxamineIron Chelating AgentsGastroenterologylaw.inventionchemistry.chemical_compoundBasal (phylogenetics)Randomized controlled triallawInternal medicineHumansMedicineBlood TransfusionDeferiproneChildMolecular Biologybusiness.industryCell BiologyHematologyMiddle Agedmedicine.diseaseSurvival AnalysisSurgeryDeferoxamineItalychemistrySupportive psychotherapyFerritinsCohortLinear ModelsMolecular MedicineFemalebusinessDeferipronemedicine.drugBlood Cells, Molecules, and Diseases
researchProduct

Rasburicase-induced Methemoglobinemia: A Case Report and Literature Review.

2020

Rasburicase is a recombinant urate oxidase enzyme indicated for tumor lysis syndrome, a potential life-threatening oncologic emergency that occurs most commonly during initial chemotherapy for hematological malignancies. As a result of the defects in the physiological antioxidant pathway, erythrocytes of patients with glucose-6-phosphate dehydrogenase deficiency are not protected against the oxidizing stress exerted by hydrogen peroxide generated with the administration of rasburicase. The authors report a 14-year-old patient, diagnosed with T-cell acute lymphoblastic leukemia, who developed methemoglobinemia and hemolytic anemia with low oxygen saturation after starting steroids, hyperhydr…

Hemolytic anemiaMalemedicine.medical_specialtyAnemia HemolyticAdolescentUrate Oxidasemedicine.medical_treatmentMethemoglobinemiaPrecursor T-Cell Lymphoblastic Leukemia-LymphomaGastroenterologyLow oxygen saturationhemic and lymphatic diseasesInternal medicinemedicineRasburicaseHumansChemotherapybusiness.industryHematologymedicine.diseaseHemolysisRecombinant ProteinsTumor lysis syndromeOncologySupportive psychotherapyPediatrics Perinatology and Child HealthbusinessMethemoglobinemiamedicine.drugJournal of pediatric hematology/oncology
researchProduct

Osteoradionecrosis and Antiresorptive Drug-Related Osteonecrosis of the Jaws

2019

With similar clinical appearances, osteoradionecrosis and antiresorptive drug-related osteonecrosis of the jaw (ARONJ) are different side effects of treatment regimens of mostly malignant diseases. While radiotherapy is usually used to control the progress of locoregional tumors, antiresorptive agents are administered in patients with generalized catabolic bone diseases. Although surgical techniques to treat both diseases are comparable, it should be noted that the pathophysiology is different. For the different genesis of both entities, they are dealt with separately in the following chapter.

OncologyDrugmedicine.medical_specialtyTreatment regimenbusiness.industryOsteoradionecrosismedicine.medical_treatmentmedia_common.quotation_subjectmedicine.diseaseRadiation therapyDenosumabSupportive psychotherapyInternal medicinemedicineIn patientOsteonecrosis of the jawbusinessmedia_commonmedicine.drug
researchProduct

Informal caregiving burden in advanced non-small cell lung cancer: the HABIT study.

2007

Introduction This study's aim was to assess economic data regarding the home assistance burden for advanced non-small cell lung cancer (NSCLC) patients in Italy. Patients and Methods One hundred four NSCLC patients in second-line chemotherapy (2LC) or in supportive therapy (ST) were enrolled in 18 Italian oncology departments and were observed for 3 months. The main caregiver's workload was assessed monthly by a task scale; other caregivers' activities were also registered. Eastern Cooperative Oncology Group performance status was assessed by physicians, and patients completed the Lung Cancer Symptoms (LCS) subscale. Formal caregiving time was valued according to market prices; informal car…

Pulmonary and Respiratory MedicineAdultMalemedicine.medical_specialtyLung NeoplasmsHome Nursingmedia_common.quotation_subjectAntineoplastic Agentscaregiving burden in advanced non-small cell lung cancerNSCLCQuality of lifeCost of IllnessCarcinoma Non-Small-Cell LungmedicineHumansLung cancermedia_commonAgedAged 80 and overbusiness.industrySocial SupportWorkloadAssistance burdenHealth Care CostsMiddle Agedmedicine.diseaseOncologyCaregiversItalySocioeconomic FactorsInformal caregivingSpouseSupportive psychotherapyScale (social sciences)Family medicinePhysical therapyCosts and Cost AnalysisQuality of LifeFemaleHabitNon small cellbusiness
researchProduct

Spontaneous pneumomediastinum and subcutaneous emphysema as a complication of asthma in children: case report and literature review

2016

Background:Spontaneous pneumomediastinum (SPM) is an uncommon disorder. It is rarely reported in paediatric patients and may be accompanied by subcutaneous emphysema. It is usually benign and self-limiting, with only supportive therapy being needed, but severe cases may require invasive measures. Asthma exacerbations have classically been described as a cause of SPM. However, detailed descriptions in asthmatic children are scarce. We aimed at improving the current understanding of the features of SPM and subcutaneous emphysema, and outcomes, by means of a case report and a systematic review.Methods:For the systematic review a literature search was performed in PubMed to identify reported ca…

Pulmonary and Respiratory MedicinePediatricsmedicine.medical_specialtyspontaneous pneumomediastinumUncommon disorder03 medical and health sciences0302 clinical medicinechildrensystematic review030225 pediatricsMedicinecase reportHumansPharmacology (medical)Sublingual immunotherapy030212 general & internal medicineAnti-Asthmatic AgentsChildMediastinal EmphysemaAsthmaOriginal Researchlcsh:RC705-779business.industryAsthma symptomssubcutaneous emphysemalcsh:Diseases of the respiratory systemasthmamedicine.diseaseDyspneaTreatment OutcomeCoughSupportive psychotherapyAnesthesiaSpontaneous pneumomediastinumFemalemedicine.symptombusinessComplicationSubcutaneous emphysemaTherapeutic Advances in Respiratory Disease
researchProduct

Randomized clinical trial of prophylactic transanal irrigation versus supportive therapy to prevent symptoms of low anterior resection syndrome after…

2019

Background Low anterior resection syndrome (LARS) is a frequent problem after rectal resection. Transanal irrigation (TAI) has been suggested as an effective treatment in patients who have developed LARS. This prospective RCT was undertaken to evaluate the effect of TAI as a prophylactic treatment to prevent symptoms of LARS. Methods Patients who had undergone ultralow rectal resection were randomized to start TAI on a daily basis, or to serve as a control with supportive therapy only after ileostomy closure. All patients were seen after 1 week, 1 month and 3 months, and the maximum number of defaecation episodes per day and night documented during follow-up. Wexner score, LARS score and Sh…

medicine.medical_specialtyLow Anterior Resectionbusiness.industrylcsh:Surgerylcsh:RD1-811General MedicineTransanal irrigationlaw.inventionSurgeryRandomized controlled triallawSupportive psychotherapymedicineDefecationIn patientRectal resectionbusinessIleostomy closurehuman activities
researchProduct

Accuracy of SCORTEN and ABCD‐10 to predict mortality and the influence of renal function in Stevens–Johnson syndrome/toxic epidermal necrolysis

2020

Epidermal necrolysis (EN) compromises a spectrum of life-threatening dermatoses (Stevens-Johnson Syndrome [SJS], overlap syndrome and toxic epidermal necrolysis [TEN]). Currently, no active therapeutic regimen with unequivocal benefit exists for SJS/TEN. SCORTEN is the widely-used prognostic scale specific for SJS/TEN. Nevertheless, a new prognostic scale, the ABCD-10, has been recently proposed. In this context, acute renal failure (ARF) seems to be an important comorbidity that could influence prognosis in SJS/TEN patients more than it is assumed by these two scales. Our objectives were to compare the accuracy of the SCORTEN and ABCD-10 scales in predicting the mortality in SJS/TEN, and t…

medicine.medical_specialtyRenal functionContext (language use)ComorbidityDermatologyEtanercept030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineAdrenal Cortex HormonesInternal medicinemedicineHumansRetrospective Studiesbusiness.industryOverlap syndromeStevens johnsonGeneral MedicinePrognosismedicine.diseaseComorbidityToxic epidermal necrolysisstomatognathic diseasesSupportive psychotherapyStevens-Johnson Syndrome030220 oncology & carcinogenesisbusinessmedicine.drugThe Journal of Dermatology
researchProduct

Symptomatic and Ancillary Therapy

2010

Although enzyme replacement therapy has had a considerable impact on the management of patients with Fabry disease, it is essential that attention is also given to supportive therapy. In this chapter a general overview about ancillary therapy is given. The great variability of clinical symptoms faced by patients with Fabry disease need the involvement from many different specialists, as well as a wide range of concomitant treatments. Coordinating a good multidisciplinary approach for each patient and ensuring that treatment is made as convenient as possible may offer a more positive impact on the quality of life of those patients affected by Fabry disease.

medicine.medical_specialtybusiness.industryMultidisciplinary approachSupportive psychotherapyConcomitantmedicineEnzyme replacement therapyIntensive care medicinebusinessmedicine.diseaseFabry disease
researchProduct